Astera Labs, Inc. $ALAB Shares Sold by National Pension Service

National Pension Service decreased its stake in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 20.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 209,418 shares of the company’s stock after selling 54,402 shares during the period. National Pension Service owned approximately 0.12% of Astera Labs worth $101,153,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Eurizon Capital SGR S.p.A. purchased a new position in Astera Labs in the fourth quarter valued at about $18,708,000. Swedbank AB increased its holdings in Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in shares of Astera Labs in the 4th quarter valued at approximately $499,000. Revere Asset Management Inc acquired a new position in shares of Astera Labs in the 4th quarter valued at approximately $589,000. Finally, Banque Cantonale Vaudoise boosted its stake in shares of Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after buying an additional 3,229 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Trading Down 5.3%

ALAB stock opened at $284.53 on Friday. The firm has a market cap of $49.36 billion, a P/E ratio of 140.86 and a beta of 3.77. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The stock’s 50 day simple moving average is $318.90 and its 200 day simple moving average is $259.95.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. The firm’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on ALAB. Morgan Stanley raised their price target on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Evercore reaffirmed an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Jefferies Financial Group increased their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Needham & Company LLC raised their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Finally, Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $348.33.

View Our Latest Report on ALAB

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the sale, the director directly owned 3,970 shares of the company’s stock, valued at approximately $1,237,965.10. This represents a 69.38% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 592,244 shares of company stock worth $209,729,973. Company insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

(Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.

Recommended Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.